NISISCO Side Effects

6333443-X | Blister, Intra-abdominal Haematoma, Leukocytoclastic Vasculitis, Lung Disorder, Nodule, Petechiae, Purpura, Skin Lesion, Skin Necrosis
on Aug 18, 2009 Male patient from FRANCE , 58 years of age, was treated with Nisisco (View Usage). Patient experienced the following unwanted or unexpected effects: blister, intra-abdominal haematoma, leukocytoclastic vasculitis, lung disorder, nodule, petechiae, purpura, skin lesion, skin necrosis. Nisisco dosage: 160/12.5mg. During the same period patient was treated with AMBROXOL (Unk) (View Ambroxol Review and Ambroxol Label ), DILTIAZEM (200 Mg, Unk) (View Diltiazem Review and Diltiazem Label ), SERETIDE DISKUS (View Seretide Diskus Review and Seretide Diskus Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), XYZAL (View Xyzal Review and Xyzal Label ). Patient was hospitalized.

6110555-7 | Balance Disorder, Confusional State, Dizziness, Fall, Hypokalaemia, Hyponatraemia, Malaise
Patient was taking Nisisco (View Usage). Patient had the following side effects: balance disorder, confusional state, dizziness (What is dizziness?), fall (What is fall?), hypokalaemia, hyponatraemia, malaise on Feb 25, 2009 from FRANCE Additional patient health information: Female patient , 64 years of age, was diagnosed with hypertension, depression (What is depression?) and. Nisisco dosage: 160/25 Mg. During the same period patient was treated with EFFEXOR (75 Mg) (View Effexor Review and Effexor Label ). Patient was hospitalized.

6096991-6 | Alpha 2 Globulin Increased, Beta Globulin Decreased, Biopsy Kidney Abnormal, Blood Albumin Decreased, Blood Immunoglobulin M, Glomerulonephritis Membranous, Hypogammaglobulinaemia, Nephrotic Syndrome
Adverse event was reported on Feb 13, 2009 by a Male patient taking Nisisco (View Usage) (Dosage: Unk) was diagnosed with hypertension, type 2 diabetes mellitus and. Location: FRANCE , 67 years of age, After Nisisco was administered, patient had the following side effects: alpha 2 globulin increased, beta globulin decreased, biopsy kidney abnormal, blood albumin decreased, blood immunoglobulin m, glomerulonephritis membranous, hypogammaglobulinaemia, nephrotic syndrome. During the same period patient was treated with LOGIMAX (View Logimax Review and Logimax Label ), AVANDAMET (Unk) (View Avandamet Review and Avandamet Label ). Patient was hospitalized.

5708547-2 | Asthenia, Dizziness, Fatigue, Hyperhidrosis, Loss Of Consciousness, Malaise, Renin Decreased, Sleep Disorder
on Apr 08, 2008 Female patient from FRANCE , 13 years of age, was treated with Nisisco (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), fatigue, hyperhidrosis, loss of consciousness, malaise, renin decreased, sleep disorder (What is sleep disorder?). Nisisco dosage: . During the same period patient was treated with SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), HEPT A MYL (View Hept-a-myl Review and Hept-a-myl Label ), EUPHYTOSE (View Euphytose Review and Euphytose Label ), EFFERALGAN (View Efferalgan Review and Efferalgan Label ), SERESTA (View Seresta Review and Seresta Label ), DEROXAT (View Deroxat Review and Deroxat Label ), NOCTAMID (View Noctamid Review and Noctamid Label ). Patient was hospitalized.


5343486-0 | Thrombocytopenic Purpura
on May 28, 2007 Male patient from FRANCE , 71 years of age, was diagnosed with hypertension and was treated with Nisisco (View Usage). Patient had the following side effects: thrombocytopenic purpura. Nisisco dosage: 1 Df, Qd. Patient was hospitalized.

5334301-X | Abdominal Pain, Atrioventricular Block First Degree, Blood Creatinine Increased, Blood Urea Increased, Bradycardia, Cardiac Arrest, Cardiac Massage, Fluid Replacement, Haemodialysis
Patient was taking Nisisco (View Usage). After Nisisco was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), atrioventricular block first degree, blood creatinine increased, blood urea increased, bradycardia, cardiac arrest (What is cardiac arrest?), cardiac massage, fluid replacement, haemodialysis on May 21, 2007 from GERMANY Additional patient health information: Male patient , 68 years of age, was diagnosed with hypertension, diabetes mellitus insulin-dependent and. Nisisco dosage: . During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), AMLOR (View Amlor Review and Amlor Label ), TILDIEM (View Tildiem Review and Tildiem Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), CRESTOR (View Crestor Review and Crestor Label ), MIXTARD /POL/ (View Mixtard /pol/ Review and Mixtard /pol/ Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5282882-7 | Biopsy Kidney Abnormal, Blood Albumin Decreased, Glomerulonephritis Membranous, Nephrotic Syndrome, Protein Urine Present, Weight Increased
Adverse event was reported on Mar 19, 2007 by a Male patient taking Nisisco (View Usage) (Dosage: Unk, Unk) was diagnosed with hypertension, diabetes mellitus non-insulin-dependent and. Location: FRANCE , 67 years of age, Patient experienced the following unwanted or unexpected effects: biopsy kidney abnormal, blood albumin decreased, glomerulonephritis membranous, nephrotic syndrome, protein urine present, weight increased. During the same period patient was treated with LOGIMAX (View Logimax Review and Logimax Label ), AVANDAMET (View Avandamet Review and Avandamet Label ). Patient was hospitalized.

5235242-9 | Anaemia Macrocytic, Blood Folate Decreased, Blood Immunoglobulin E Increased, C-reactive Protein Increased, Fatigue, Full Blood Count Decreased, Gastroenteritis, Haemoglobin Decreased, Libido Decreased
on Jan 30, 2007 Male patient from FRANCE , 75 years of age, was diagnosed with hypertension and was treated with Nisisco (View Usage). Patient had the following side effects: anaemia macrocytic, blood folate decreased, blood immunoglobulin e increased, c-reactive protein increased, fatigue, full blood count decreased, gastroenteritis (What is gastroenteritis?), haemoglobin decreased, libido decreased. Nisisco dosage: 1 Df, Qd.

5192745-3 | Anaemia Macrocytic, Blood Folate Decreased, Blood Immunoglobulin E Increased, C-reactive Protein Increased, Fatigue, Full Blood Count Decreased, Gastroenteritis, Haemoglobin Decreased, Libido Decreased
on Nov 28, 2006 Male patient from FRANCE , 75 years of age, was diagnosed with hypertension and was treated with Nisisco (View Usage). After Nisisco was administered, patient had the following side effects: anaemia macrocytic, blood folate decreased, blood immunoglobulin e increased, c-reactive protein increased, fatigue, full blood count decreased, gastroenteritis (What is gastroenteritis?), haemoglobin decreased, libido decreased. Nisisco dosage: 1 Df, Qd.

5167812-0 | Bone Marrow Failure, Fatigue, Gastroenteritis, Haemoglobin Decreased, Libido Decreased, Lymphocyte Count Increased, Macrocytosis, Neutrophil Count Decreased, Platelet Count Decreased
Patient was taking Nisisco (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, fatigue, gastroenteritis (What is gastroenteritis?), haemoglobin decreased, libido decreased, lymphocyte count increased, macrocytosis, neutrophil count decreased, platelet count decreased on Nov 28, 2006 from FRANCE Additional patient health information: Male patient , 75 years of age, was diagnosed with hypertension and. Nisisco dosage: 1 Df, Qd.

5025614-X | Difficulty In Walking, Muscular Weakness, Myalgia, Osteoarthritis, Polymyalgia Rheumatica, Rhabdomyolysis
Adverse event was reported on Jun 08, 2006 by a Male patient taking Nisisco (View Usage) (Dosage: 1 Df, Qd) was diagnosed with hypertension, thrombosis prophylaxis and. Location: FRANCE , 64 years of age, Patient had the following side effects: difficulty in walking, muscular weakness, myalgia, osteoarthritis (What is osteoarthritis?), polymyalgia rheumatica (What is polymyalgia rheumatica?), rhabdomyolysis. During the same period patient was treated with AMLOR (View Amlor Review and Amlor Label ), PREVISCAN (30 Mg/day) (View Previscan Review and Previscan Label ). Patient was hospitalized.

4988462-2 | Abnormal Behaviour, Agitation, Confusional State, Hyponatraemia
on Apr 20, 2006 Female patient from FRANCE , 89 years of age, was diagnosed with hypertension, confusional state and was treated with Nisisco (View Usage). After Nisisco was administered, patient had the following side effects: abnormal behaviour, agitation, confusional state, hyponatraemia. Nisisco dosage: 1 Df, Qd. During the same period patient was treated with PAROXETINE HYDROCHLORIDE (20 Mg, Qd) (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), UTEPLEX (View Uteplex Review and Uteplex Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), CORDARONE (View Cordarone Review and Cordarone Label ), NIDREL (View Nidrel Review and Nidrel Label ). Patient was hospitalized.

4900094-0 | Anorexia, Asthenia, Blood Creatinine Increased, Renal Failure Acute, Tremor, Weight Decreased
on Jan 30, 2006 Female patient from FRANCE , 66 years of age, was diagnosed with hypertension, bipolar i disorder, diabetes mellitus and was treated with Nisisco (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, asthenia, blood creatinine increased, renal failure acute, tremor, weight decreased. Nisisco dosage: 2 Df, Qd. During the same period patient was treated with TERALITHE (4 Df/day) (View Teralithe Review and Teralithe Label ), LERCAN (1 Df, Qd) (View Lercan Review and Lercan Label ), NOVONORM (3 Df/day) (View Novonorm Review and Novonorm Label ), LEXOMIL (Unk, Unk) (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

4852567-7 | Cough, Dyspnoea Exertional, Interstitial Lung Disease, Pulmonary Function Test Decreased
Patient was taking Nisisco (View Usage). Patient had the following side effects: cough, dyspnoea exertional, interstitial lung disease, pulmonary function test decreased on Nov 30, 2005 from FRANCE Additional patient health information: Female patient , 70 years of age, was diagnosed with hypertension and. Nisisco dosage: . During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

4676085-4 | Alpha 2 Globulin Increased, Inflammation, Red Blood Cell Sedimentation Rate Increased, Vascular Purpura
Adverse event was reported on May 09, 2005 by a Male patient taking Nisisco (View Usage) (Dosage: 1 Df, Qd) was diagnosed with hypertension, bronchitis viral and. Location: , 68 years of age, After Nisisco was administered, patient had the following side effects: alpha 2 globulin increased, inflammation, red blood cell sedimentation rate increased, vascular purpura. During the same period patient was treated with CARBOCISTEINE (2 Spoons Full/day) (View Carbocisteine Review and Carbocisteine Label ).

4669535-0 | Alpha 2 Globulin Increased, Inflammation, Red Blood Cell Sedimentation Rate Increased, Vascular Purpura
on May 09, 2005 Male patient from , 68 years of age, was diagnosed with hypertension, bronchitis viral and was treated with Nisisco (View Usage). Patient experienced the following unwanted or unexpected effects: alpha 2 globulin increased, inflammation, red blood cell sedimentation rate increased, vascular purpura. Nisisco dosage: 1 Df, Qd. During the same period patient was treated with CARBOCISTEINE (2 Spoons Full/day) (View Carbocisteine Review and Carbocisteine Label ).

4662203-0 | Abdominal Pain Upper, Blood Creatinine Increased, Blood Lactic Acid Increased, Blood Ph Decreased, Decreased Appetite, Gastric Ulcer Perforation, Gastric Ulcer Surgery, Haemodialysis, Hypoglycaemia
on Apr 22, 2005 Female patient from , 62 years of age, weighting 88.18 lb, was diagnosed with diabetes mellitus non-insulin-dependent, upper respiratory tract infection, hypertension, dyslipidaemia and was treated with Nisisco (View Usage). Patient had the following side effects: abdominal pain upper, blood creatinine increased, blood lactic acid increased, blood ph decreased, decreased appetite, gastric ulcer perforation, gastric ulcer surgery, haemodialysis, hypoglycaemia. Nisisco dosage: 1 Df, Qd. During the same period patient was treated with GLUCOPHAGE (1 G, Qd) (View Glucophage Review and Glucophage Label ), DIAMICRON (4 Df, Qd) (View Diamicron Review and Diamicron Label ), ROCEPHIN (1 G, Qd) (View Rocephin Review and Rocephin Label ), ICAZ (5 Mg, Qd) (View Icaz Review and Icaz Label ), LESCOL (View Lescol Review and Lescol Label ), PROFENID (100 Mg, Qd) (View Profenid Review and Profenid Label ). Patient was hospitalized.

4647667-0 | Abdominal Pain Upper, Blood Creatinine Increased, Blood Lactic Acid Increased, Blood Ph Decreased, Decreased Appetite, Gastric Ulcer Perforation, Gastric Ulcer Surgery, Hypoglycaemia, Infection
Patient was taking Nisisco (View Usage). After Nisisco was administered, patient had the following side effects: abdominal pain upper, blood creatinine increased, blood lactic acid increased, blood ph decreased, decreased appetite, gastric ulcer perforation, gastric ulcer surgery, hypoglycaemia, infection (What is infection?) on Apr 22, 2005 from Additional patient health information: Female patient , 62 years of age, weighting 88.18 lb, was diagnosed with hypertension, infection (What is infection?), dyslipidaemia and. Nisisco dosage: 1 Df, Qd. During the same period patient was treated with GLUCOPHAGE (1 G, Qd) (View Glucophage Review and Glucophage Label ), DIAMICRON (4 Df, Qd) (View Diamicron Review and Diamicron Label ), ROCEPHIN (1 G, Qd) (View Rocephin Review and Rocephin Label ), ICAZ (5 Mg, Qd) (View Icaz Review and Icaz Label ), LESCOL (View Lescol Review and Lescol Label ), PROFENID (100 Mg, Qd) (View Profenid Review and Profenid Label ). Patient was hospitalized.